Table 1 Study characteristics.
From: A systematic review and meta-analysis of obesity and COVID-19 outcomes
Author, year | Location | Study type | n | Incl. (n) | Excluded (n) | Excluded reason | Ages included (y) | Age (y) | Obesity (kg/m2) | Extractable outcome (s) | Sex | Ethnicity | Study setting | SES | Pre-existing conditions | Meds |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Busetto et al.13 | Padova, Italy | RC | 92 | 92 | 0 | n/a | 40–96 | Mean 70.5 (SD 13.3) | BMI ≥ 30 | IMV, ICU, D | Male and female | NR | W | NR | DM2 (30.4%), HF (31.5%) | NR |
Cai et al.14 | Shenzhen, Guangdong China | RC | 383 | 383 | 0 | n/a | ≥ 18 | NR | BMI ≥ 28 | IMV, ICU, S, D | Male and female | Asian | W | NR | NR | NR |
Caussy et al.6 | Lyon, France | RC | 357 | 340 | 17 | BMI unknown | ≥ 18 | NR | BMI ≥ 30 | ICU | NR | NR | W, ICU | NR | DM2 (21%), HF (26%) | NR |
Chao et al.15 | New York, NY, USA | RC | 47 | 47 | 0 | n/a | < 21 | Median 13.1 (IQR 0.4–19.3) | BMI ≥ 30 | IMV, ICU, ARDS, D | Male and female | White 1 (3%), Black 3 (9.1%), Latino 26 (78.8%), Other 3 (9.1%) | OP, W, ICU | NR | NR | NR |
Docherty et al.20 | United Kingdom | PC | 20,133 | 11,222 | 8911 | 4052 BMI unknown; 4859 still receiving care | 0–104 | Median 73 (IQR 58–82) | "clinician-defined" | D | Male and female | NR | W | NR | DM2 (20.7%) | NR |
Dreher et al.26 | Aachen, Germany | RC | 50 | 50 | 0 | n/a | NR | Median 65 (IQR 58–76) | BMI ≥ 30 | ARDS | Male and female | NR | W, ICU | NR | DM2 (58%) | NR |
Goyal et al.10 | New York, NY, USA | RC | 393 | 380 | 13 | BMI unknown | ≥ 18 | Median 62.2 (IQR 48.6–73.7) | BMI ≥ 30 | IMV | Male and female | White 147 (37.4%), Non-white 246 (62.6%) | W | NR | DM2 (25.2%) | NR |
Hu et al.27 | Wuhan, China | RC | 323 | 294 | 29 | BMI Unknown | 23–91 | Median 62 | BMI ≥ 30 | S | Male and female | Asian | W | NR | NR | AVT, Abx, CS |
Huang et al.28 | Jiansu, China | RC | 202 | 172 | 30 | BMI unknown | NR | Median 44 (IQR 33–54) | BMI ≥ 28 | S | Male and female | Asian | W | NR | NR | NR |
ICNARC 29 | United Kingdom | RC | 9347 | 7521 | 1826 | 709 BMI unknown; 1117 still receiving care | ≥ 16 | Median 60 (IQR 51–68) | BMI ≥ 30 | D | Male and female | White 5690 (67%), Mixed 145 (1.7%), 1275 (15%), Black (9.8%), Other 555(6.5%) | W | NR | NR | NR |
Kalligeros et al.16 | Providence and Newport, RI, USA | RC | 103 | 103 | 0 | n/a | ≥ 18 | Median 60 (52–70) | BMI ≥ 30 | ICU | Male and female | White 42 (40.7%), Black 24 (23.3%), Hispanic (35 (33.9%), Asian 2 (1.9%) | W, ICU | NR | DM2 (36.8%),HF (24.2%) | NR |
Killerby et al.12 | Atlanta, GA, USA | RC | 531 | 436 | 95 | BMI unknown | ≥ 18 | Median 61 (no IQR shown) | BMI ≥ 30 | H | Male and female | White 119 (22.4%), Black 313 (58.9%), Other 17 (3.3%), Unknown 82 (15.4%) | OP, W | NR | DM2 (25.5%) | NR |
Lighter et al.9 | New York, NY, USA | RC | 3615 | 1762 | 0 | n/a | NR | NR | BMI ≥ 30 | ICU | NR | NR | W | NR | NR | NR |
Moriconi et al.21 | Pisa, Italy | RC | 100 | 100 | 0 | n/a | NR | NR | BMI ≥ 30 | D | Male and female | NR | W | NR | NR | NR |
Ong et al.17 | Tan Tock Seng, Singapore | RC | 182 | 91 | 91 | BMI unknown | NR | NR | BMI ≥ 25 | IMV, ICU, D | Male and female | Asian | W | NR | NR | NR |
Peng et al.11 | Wuhan, Hubei, China | RC | 112 | 112 | 0 | BMI unknown | ≥ 18 | Median 62 (IQR 55–67) | BMI ≥ 25 | D | Male and female | Asian | W | NR | CVD | ACEI/ARB |
Petrilli et al.5 | New York, NY, USA | RC | 5279 | 5040 | 239 | BMI unknown | ≥ 19 | Median 54 (IQR 38–66) | BMI ≥ 30 | H | Male and female | White 2003 (37.9%), African American 835 (15.8%), Asian 383 (7.3%), Hispanic 1330 (25.2%), Other 397 (7.5%), Unknown 331 (6.3%) | OP, W | NR | DM2 (22.6%) | NR |
Rosenberg et al.22 | New York, NY, USA | RC | 1438 | 1030 | 408 | BMI unknown | NR | Median 63 | BMI ≥ 30 | D | Male and female | White 167 (24.1%), Black 199 (28.7%), Hispanic 199 (28.7%), Other 128 (18.5%) | W | NR | DM2 (48.9%) | HC or Z |
Simonnet et al.8 | Lille, France | RC | 124 | 124 | 0 | n/a | NR | Median 60 (IQR 51–70) | BMI ≥ 30 | IMV | Male and female | NR | ICU | NR | DM2 (23%) | NR |
Suleyman et al.18 | Detroit, MI, USA | RC | 463 | 463 | 0 | n/a | NR | Mean 57.5 (SD 16.8) | Assumed BMI ≥ 30 given study location | H, ICU | Male and female | African American 334 (72.1%), Non-African American 129 (27.9%) | W, ICU | NR | DM2 (38.4%) | Abx |
Toussie et al.19 | New York, NY, USA | RC | 338 | 313 | 25 | BMI unknown | 21–50 | Median 39 (IQR 31–45) | BMI ≥ 30 | IMV, H | Male and female | White 71 (21%), Asian 30 (9%), Black 78 (23%), Hispanic116 (34%), Unknown 43 (13%) | OP, W | NR | NR | NR |
Zheng et al.30 | Wenzhou, China | RC | 66 | 66 | 0 | n/a | 18–75 | Mean 47 (no SD shown) | BMI ≥ 25 | S | Male and female | Asian | W | NR | DM2 (24.2%) | COVID-19 Management guidance (7th edition) |
